The 2025 International Hydrogen Energy Conference is just around the corner, and the supply and demand in various segments of the hydrogen energy market are expected to experience double growth.

From March 26 to 28, the "2025 International Hydrogen Energy Conference and International Hydrogen Energy and Fuel Cell Industry Exhibition" hosted by the CHINA POWER Alliance and the China Electricity Council will be held at the National Conference Center in Peking. According to Research Reports by Everbright, in 2020, the penetration rate of green hydrogen in China was about 2%. Since 2021, the number of green hydrogen demonstration projects in China has continued to grow, and water electrolysis hydrogen production has entered a new stage of large-scale demonstration.

cls.cnMar 23 19:26 ET

The price of beef cattle is "constantly falling". Fortune Ng Fung Food's 2024 performance decline is nearly 50%丨Interpretations

1. Fortune Ng Fung Food's revenue and net income for 2024 both declined, with net income of 51.7 million yuan, down 47.56% year-on-year; 2. The company explained in its annual report that the significant drop in domestic live cattle and beef prices directly led to an increase in beef sales without an increase in profit; 3. Since the fourth quarter of last year, the pace of live cattle slaughter has noticeably accelerated in the domestic market, and the overall trend for domestic breeding cows has been a reduction, with the industry expecting a potential reversal and increase in beef prices by 2025.

cls.cnMar 21 09:36 ET

It is proposed to set aside a goodwill impairment provision of nearly 0.9 billion yuan. China National Accord Medicines Corporation's revenue and net profit are expected to decline in 2024 | Quick Announcement.

① Due to the combined impact of intensified market competition and other factors, China National Accord Medicines Corporation expects a decline in both revenue and Net income for 2024. ② The company plans to make an impairment provision totaling 1.094 billion yuan for credit impairment losses and asset impairment losses.

cls.cnMar 17 10:13 ET

The "hot battle" of humanoid robots has begun: frequent release of new products. Is the year of mass production really here? | Industry observation

① Siasun Robot&Automation and Zhiyuan Robot both launched new humanoid robots, and related Concept stocks rose in response; ② mass production of humanoid robots still faces challenges, and domestic manufacturers aim to produce thousands of units this year; ③ there are also disputes within the Industry regarding the implementation scenarios.

cls.cnMar 12 00:30 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

The Robot Concept is experiencing explosive growth! The strongest stock has risen nearly 7 times, and these stocks have all reached new historical highs.

YuTree Technology's Wang Xingxing recently stated that by the end of this year, the entire humanoid robot in the field of AI will reach a new level.

cls.cnFeb 19 01:30 ET